[en] The development of osteoinductive calcium phosphate- (CaP) based biomaterials has, and continues to be, a major focus in the field of bone tissue engineering. However, limited insight into the spatiotemporal activation of signalling pathways has hampered the optimisation of in vivo bone formation and subsequent clinical translation. To gain further knowledge regarding the early molecular events governing bone tissue formation, we combined human periosteum derived progenitor cells with three types of clinically used CaP-scaffolds, to obtain constructs with a distinct range of bone forming capacity in vivo. Protein phosphorylation together with gene expression for key ligands and target genes were investigated 24 hours after cell seeding in vitro, and 3 and 12 days post ectopic implantation in nude mice. A computational modelling approach was used to deduce critical factors for bone formation 8 weeks post implantation. The combined Ca(2+)-mediated activation of BMP-, Wnt- and PKC signalling pathways 3 days post implantation were able to discriminate the bone forming from the non-bone forming constructs. Subsequently, a mathematical model able to predict in vivo bone formation with 96% accuracy was developed. This study illustrates the importance of defining and understanding CaP-activated signalling pathways that are required and sufficient for in vivo bone formation. Furthermore, we demonstrate the reliability of mathematical modelling as a tool to analyse and deduce key factors within an empirical data set and highlight its relevance to the translation of regenerative medicine strategies.
Disciplines :
Engineering, computing & technology: Multidisciplinary, general & others
Author, co-author :
Bolander, Johanna
Chai, Yoke Chin
Geris, Liesbet ; Université de Liège > Département d'aérospatiale et mécanique > Génie biomécanique
Schrooten, Jan
Lambrechts, Dennis
Roberts, Scott J.
Luyten, Frank P.
Language :
English
Title :
Early BMP, Wnt and Ca(2+)/PKC pathway activation predicts the bone forming capacity of periosteal cells in combination with calcium phosphates.
Publication date :
2016
Journal title :
Biomaterials
ISSN :
0142-9612
eISSN :
1878-5905
Publisher :
Elsevier, United Kingdom
Volume :
86
Pages :
106-18
Peer reviewed :
Peer Reviewed verified by ORBi
European Projects :
FP7 - 279100 - BRIDGE - Biomimetic process design for tissue regeneration: from bench to bedside via in silico modelling
Funders :
CE - Commission Européenne
Commentary :
Copyright (c) 2016 Elsevier Ltd. All rights reserved.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Oryan A., Alidadi S., Moshiri A., Maffulli N. Bone regenerative medicine: classic options, novel strategies, and future directions. J. Orthop. Surg. Res. 2014, 9:18.
Lenas P., Moos M., Luyten F.P. Developmental engineering: a new paradigm for the design and manufacturing of cell-based products. Part I: from three-dimensional cell growth to biomimetics of in vivo development. Tissue Eng. B Rev. 2009, 15:381-394.
Roberts S.J., Geris L., Kerckhofs G., Desmet E., Schrooten J., Luyten F.P. The combined bone forming capacity of human periosteal derived cells and calcium phosphates. Biomaterials 2011, 32:4393-4405.
Eyckmans J., Roberts S.J., Schrooten J., Luyten F.P. A clinically relevant model of osteoinduction: a process requiring calcium phosphate and BMP/Wnt signalling. J. Cell. Mol. Med. 2010, 14:1845-1856.
Eyckmans J., Roberts S.J., Bolander J., Schrooten J., Chen C.S., Luyten F.P. Mapping calcium phosphate activated gene networks as a strategy for targeted osteoinduction of human progenitors. Biomaterials 2013, 34:4612-4621.
Chai Y.C., Roberts S.J., Desmet E., Kerckhofs G., van Gastel N., Geris L., et al. Mechanisms of ectopic bone formation by human osteoprogenitor cells on CaP biomaterial carriers. Biomaterials 2012, 33:3127-3142.
Platt M.O., Wilder C.L., Wells A., Griffith L.G., Lauffenburger D.A. Multipathway kinase signatures of multipotent stromal cells are predictive for osteogenic differentiation: tissue-specific stem cells. Stem cells 2009, 27:2804-2814.
Geris L. Regenerative orthopaedics: in vitro, in vivo...in silico. Int. Orthop. 2014, 38:1771-1778.
Li J., Wu Z., Cheng F., Li W., Liu G., Tang Y. Computational prediction of microRNA networks incorporating environmental toxicity and disease etiology. Sci. Rep. 2014, 4:5576.
Ajmera I., Swat M., Laibe C., Novere N.L., Chelliah V. The impact of mathematical modeling on the understanding of diabetes and related complications. CPT Pharmacomet. Syst. Pharmacol. 2013, 2:e54.
Haeno H., Gonen M., Davis M.B., Herman J.M., Iacobuzio-Donahue C.A., Michor F. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell 2012, 148:362-375.
Kovatchev B.P., Breton M., Man C.D., Cobelli C. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J. Diabetes Sci. Technol. 2009, 3:44-55.
FDA Advancing Regulatory Science at FDA: a strategic plan 2011, FDA, US. Services UDoHaH (Ed.).
De Bari C., Dell'Accio F., Karystinou A., Guillot P.V., Fisk N.M., Jones E.A., et al. A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthr. Rheum. 2008, 58:240-250.
Raspopovic J., Marcon L., Russo L., Sharpe J. Modeling digits. Digit patterning is controlled by a Bmp-Sox9-Wnt Turing network modulated by morphogen gradients. Science 2014, 345:566-570.
Janes K.A., Albeck J.G., Gaudet S., Sorger P.K., Lauffenburger D.A., Yaffe M.B. A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science 2005, 310:1646-1653.
Miller-Jensen K., Janes K.A., Brugge J.S., Lauffenburger D.A. Common effector processing mediates cell-specific responses to stimuli. Nature 2007, 448:604-608.
Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., Longair M., Pietzsch T., et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 2012, 9:676-682.
Lambrechts D., Roeffaers M., Kerckhofs G., Roberts S.J., Hofkens J., Van de Putte T., et al. Fluorescent oxygen sensitive microbead incorporation for measuring oxygen tension in cell aggregates. Biomaterials 2013, 34:922-929.
Kerckhofs G., Sainz J., Wevers M., Van de Putte T., Schrooten J. Contrast-enhanced nanofocus computed tomography images the cartilage subtissue architecture in three dimensions. Eur. Cells Mater. 2013, 25:179-189.
Otsu N. Threshold selection method from gray-level histograms. Ieee T Syst. Man. Cyb 1979, 9:62-66.
Martin I., Mastrogiacomo M., De Leo G., Muraglia A., Beltrame F., Cancedda R., et al. Fluorescence microscopy imaging of bone for automated histomorphometry. Tissue Eng. 2002, 8:847-852.
Bolander J., JR S., Eyckmans J., Geris L., Luyten F.P. The Effect of activating fibroblast growth factor receptor 3 mutations on osteogenic differentiation and ectopic bone formation by human periosteal derived cells. J. Tissue Sci. Eng. 2012, 2.
Chai Y.C., Roberts S.J., Schrooten J., Luyten F.P. Probing the osteoinductive effect of calcium phosphate by using an in vitro biomimetic model. Tissue Eng. Part A 2011, 17:1083-1097.
Barradas A.M., Monticone V., Hulsman M., Danoux C., Fernandes H., Tahmasebi Birgani Z., et al. Molecular mechanisms of biomaterial-driven osteogenic differentiation in human mesenchymal stromal cells. Integr. Biol. Quant. Biosci. Nanomacro 2013, 5:920-931.
Barradas A.M., Fernandes H.A., Groen N., Chai Y.C., Schrooten J., van de Peppel J., et al. A calcium-induced signaling cascade leading to osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells. Biomaterials 2012, 33:3205-3215.
Yuan H., Fernandes H., Habibovic P., de Boer J., Barradas A.M., de Ruiter A., et al. Osteoinductive ceramics as a synthetic alternative to autologous bone grafting. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:13614-13619.
Groppe J., Greenwald J., Wiater E., Rodriguez-Leon J., Economides A.N., Kwiatkowski W., et al. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 2002, 420:636-642.
Hoang B., Moos M., Vukicevic S., Luyten F.P. Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. J. Biol. Chem. 1996, 271:26131-26137.
Lin K., Wang S., Julius M.A., Kitajewski J., Moos M., Luyten F.P. The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:11196-11200.
Zhang R., Oyajobi B.O., Harris S.E., Chen D., Tsao C., Deng H.W., et al. Wnt/beta-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone 2013, 52:145-156.
Oancea E., Meyer T. Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals. Cell 1998, 95:307-318.
Mochly-Rosen D., Das K., Grimes K.V. Protein kinase C, an elusive therapeutic target?. Nat. Rev. Drug Discov. 2012, 11:937-957.
Gwak J., Cho M., Gong S.J., Won J., Kim D.E., Kim E.Y., et al. Protein-kinase-C-mediated beta-catenin phosphorylation negatively regulates the Wnt/beta-catenin pathway. J. Cell Sci. 2006, 119:4702-4709.
Wang Z., Wang K., Lu X., Li M., Liu H., Xie C., et al. BMP-2 encapsulated polysaccharide nanoparticle modified biphasic calcium phosphate scaffolds for bone tissue regeneration. J. Biomed. Mater. Res. Part A April 2015, 103(4):1520-1532.
Miyazono K. Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone 1999, 25:91-93.
Westendorf J.J., Kahler R.A., Schroeder T.M. Wnt signaling in osteoblasts and bone diseases. Gene 2004, 341:19-39.
Phimphilai M., Zhao Z., Boules H., Roca H., Franceschi R.T. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2006, 21:637-646.
Lee K.S., Kim H.J., Li Q.L., Chi X.Z., Ueta C., Komori T., et al. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell. Biol. 2000, 20:8783-8792.
Javed A., Afzal F., Bae J.S., Gutierrez S., Zaidi K., Pratap J., et al. Specific residues of RUNX2 are obligatory for formation of BMP2-induced RUNX2-SMAD complex to promote osteoblast differentiation. Cells Tissues Organs 2009, 189:133-137.
Lee M.H., Kwon T.G., Park H.S., Wozney J.M., Ryoo H.M. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem. Biophys. Res. Commun. 2003, 309:689-694.
Kamiya N., Ye L., Kobayashi T., Mochida Y., Yamauchi M., Kronenberg H.M., et al. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development 2008, 135:3801-3811.
Tsuji K., Bandyopadhyay A., Harfe B.D., Cox K., Kakar S., Gerstenfeld L., et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat. Genet. 2006, 38:1424-1429.
Dimitriou R., Tsiridis E., Giannoudis P.V. Current concepts of molecular aspects of bone healing. Injury 2005, 36:1392-1404.
Hadjiargyrou M., Lombardo F., Zhao S., Ahrens W., Joo J., Ahn H., et al. Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair. J. Biol. Chem. 2002, 277:30177-30182.
Zhong N., Gersch R.P., Hadjiargyrou M. Wnt signaling activation during bone regeneration and the role of Dishevelled in chondrocyte proliferation and differentiation. Bone 2006, 39:5-16.
Wang L., Zhang B., Bao C., Habibovic P., Hu J., Zhang X. Ectopic osteoid and bone formation by three calcium-phosphate ceramics in rats, rabbits and dogs. PloS One 2014, 9:e107044.
Santos F., Andrade P.Z., Abecasis M.M., Gimble J.M., Chase L.G., Campbell A.M., et al. Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions. Tissue Eng. Part C Methods 2011, 17:1201-1210.
Ratcliffe E., Thomas R.J., Williams D.J. Current understanding and challenges in bioprocessing of stem cell-based therapies for regenerative medicine. Br. Med. Bull. 2011, 100:137-155.
Sonnaert M., Luyten F.P., Schrooten J., Papantoniou I. Bioreactor-based online recovery of human progenitor cells with uncompromised regenerative potential: a bone tissue engineering perspective. PloS One 2015, 10:e0136875.
Kleinhans C., Mohan R.R., Vacun G., Schwarz T., Haller B., Sun Y., et al. A perfusion bioreactor system efficiently generates cell-loaded bone substitute materials for addressing critical size bone defects. Biotechnol. J. November 2015, 10(11):1727-1738.
Badraiq H., Devito L., Ilic D. Isolation and expansion of mesenchymal stromal/stem cells from umbilical cord under chemically defined conditions. Methods Mol. Biol. 2015, 1283:65-71.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.